Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Fischer Medical Ventures Ltd (FISCHER)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524743 NSE: FISCHER Trading | Small Cap | Fischer Medical Share Price
₹33.50 0.00 (0.00%)
As on 01-Oct'26 16:59
Fischer Medical Ventures Ltd (FISCHER)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524743 NSE: FISCHER Trading | Small Cap | Fischer Medical Share Price
₹33.50 0.00 (0.00%)
As on 01-Oct'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹2,341 Cr.
Current Price
₹33.5
52-Week Low / High
₹31 / 121
TTM EPS
₹0.4
TTM Sales
₹367 Cr.
Book Value per Share
₹6.7
P/E Ratio
78.48
Industry PE
38.6
Price to Book (P/B)
5.03
Lower than its 5-year historical median
Price to Sales (P/S)
6.38
Lower than its 5-year historical median
EV/EBITDA
42.34
Lower than its 5-year historical median
Dividend Yield
0.15%
Profitability Efficiency
Return on Equity (ROE)
9.38%
Outperforms industry median
Return on Capital Employed (ROCE)
12.27%
Outperforms industry median
Return on Assets (ROA)
5.53%
Operating Profit Margin
15.1%
Net Profit Margin
10.12%
Gross Profit Margin
16.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
233.14%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
1189.82%
Net Profit Growth (1 Year)
-
1748.52%
Asset Quality
Promoter Holding
62.15%
Pledged shares (%) of Promoter's holding (%)
7.38%
Reserves
₹396 Cr.
Equity
₹69.9 Cr.
Face Value
₹1
All Time Low / High
₹0.10 / 124.20
Check Before You Invest
Quality
Not GoodValuation
FairCheck Valuation charts
Price Trend
Semi Strong
Is Fischer Medical Ventures Ltd a good quality company?
Fischer Medical Ventures Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Fischer Medical Ventures Ltd performance compare with that of its Peers?
Revenue growth of Fischer Medical Ventures Ltd vs industry peers?
Fischer Medical Ventures Ltd revenue CAGR is 1096.83%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Fischer Medical Ventures Ltd?
Promoters hold 62.15% of the Fischer Medical Ventures Ltd, with 7.38% of their stake pledged, indicating low pledge risk.
Stock return of Fischer Medical Ventures Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 68.7% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Fischer Medical Ventures Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | -358.4% | 1.7% | 4.8% | -25.3% | -11.2% | -95.4% | 6.5% | 1.4% | 0.5% | -1.7% | - |
| Value Creation Index ⓘ | NA | -0.9 | -0.7 | NA | -1.8 | NA | NA | -0.9 | -1.0 | -1.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 0 | 0.2 | 0.2 | 0 | 0.2 | 11.5 | 5.2 | 17.4 | 14 |
| Sales YoY Gr. | - | NA | NA | NA | -5.6% | -100% | NA | 6,305.6% | -54.7% | 233.1% | - |
| Adj EPS ⓘ | -0 | 0 | 0 | -0.2 | 0.8 | -1.4 | -0.2 | 0 | 0 | -0.2 | -0.2 |
| YoY Gr. | - | NA | 200% | -900% | NA | -264.6% | NA | NA | 0% | -1700% | - |
| BVPS (₹) ⓘ | -0 | -0.6 | -0.6 | -0.8 | 0 | -1.3 | -1.6 | 1.5 | 4.8 | 4.8 | 5.9 |
| Adj Net Profit ⓘ | -0.1 | 0 | 0 | -0 | 0.1 | -0.2 | -0 | 0.4 | 0.5 | -10.7 | -13 |
| Cash Flow from Ops. ⓘ | -0.1 | -0 | 0 | 0 | -0.1 | -0.2 | -0.2 | 0.1 | -22.8 | -2.9 | - |
| Debt/CF from Ops. ⓘ | -1.9 | -25.2 | 78 | 18.1 | -4.1 | -2.2 | -3.9 | 0 | 0 | -4.5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 152.3% | 358.9% | 233.1% | ||||
| Adj EPS ⓘ | NA | -172.1% | NA | -1700% | ||||
| BVPSⓘ | NA | 198.9% | NA | -0.4% | ||||
| Share Price | 68.7% | 22.4% | 71.2% | -68.8% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 95.9 | -1.1 | -4.6 | 35.1 | -209.2 | 205.5 | 14.7 | 1 | 0.3 | -3.2 | -3.6 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 0 | -12.5 | -10.7 | 0 | 8.5 | -1.7 | -42.9 | -49.8 | -80.7 |
| Net Profit Mgn % ⓘ | 0 | 0 | 0 | -22.3 | 85.2 | 0 | -20.3 | 3.5 | 9.8 | -61.6 | -97.8 |
| Debt to Equity ⓘ | -1.3 | -2.3 | -2.1 | -1.6 | 75.1 | -1.7 | -2.2 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 54 | 74 | 0 | 250 | 804 | 4,115 | 1,466 | 272 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | -50 | -62 | 0 | 103 | 0 | 635 | 352 | 139 |
Valuation of Fischer Medical - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.38 | 7.38 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|
| Sales | 0 | 21 | 111 | 309 |
| Operating Expenses ⓘ + | 0 | 19 | 107 | 265 |
| Operating Profit ⓘ | 0 | 2 | 3 | 43 |
| Operating Profit Margin (%) | 8.5% | 8.9% | 3.0% | 14.0% |
| Other Income ⓘ + | 0 | 1 | 1 | 12 |
| Interest ⓘ | 0 | 0 | 0 | 6 |
| Depreciation ⓘ | 0 | 0 | 2 | 3 |
| Profit Before Tax ⓘ | -0 | 2 | 3 | 47 |
| Tax ⓘ | 0 | 0 | 1 | 15 |
| Profit After Tax | -0 | 2 | 2 | 31 |
| PAT Margin (%) | -20.3% | 8.8% | 1.5% | 10.1% |
| Adjusted EPS (₹) | -0.2 | 0.0 | 0.0 | 0.5 |
| Dividend Payout Ratio (%) | 0% | 0% | 34.10% | 11% |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | -0 | 80 | 307 | 359 | |||||||
| Debt + | 1 | 0 | 60 | 72 | |||||||
| Minority Interest | 0 | 0 | 0 | 1 | |||||||
| Trade Payables | 0 | 2 | 21 | 103 | |||||||
| Others Liabilities ⓘ | -0 | 4 | 72 | 135 | |||||||
| Total Liabilities ⓘ | 0 | 86 | 461 | 669 | |||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 0 | 15 | 24 | 32 | |||||||
| CWIP ⓘ | 0 | 0 | 1 | 3 | |||||||
| Investments ⓘ | 0 | 1 | 7 | 118 | |||||||
| Inventories | 0 | 4 | 9 | 13 | |||||||
| Trade Receivables | 0 | 23 | 76 | 289 | |||||||
| Cash Equivalents | 0 | 38 | 255 | 25 | |||||||
| Others Assets ⓘ | 0 | 5 | 88 | 191 | |||||||
| Total Assets ⓘ | 0 | 86 | 461 | 669 | |||||||
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 0 | -7 | -86 | -101 |
| Cash Flow From Investing Activity ⓘ + | 0 | -31 | -125 | -5 |
| Cash Flow From Financing Activity ⓘ + | 0 | 37 | 315 | 14 |
| Net Cash Flow ⓘ | 0 | -2 | 103 | -92 |
| PARTICULARS | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | N/A | 4.6 | 0.87 | 9.38 | ||||||
| ROCE (%) | N/A | 5.35 | 1.34 | 12.27 | ||||||
| Asset Turnover Ratio | 0.72 | 0.48 | 0.4 | 0.55 | ||||||
| PAT to CFO Conversion(x) | N/A | -3.5 | -43 | -3.26 | ||||||
| Working Capital Days | ||||||||||
| Receivable Days | 346.90 | 200.40 | 163.10 | 215.80 | ||||||
| Inventory Days | 0 | 77.90 | 22.50 | 12.90 | ||||||
| Payable Days | 0 | 24.10 | 45.50 | 115 | ||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Fischer Medical Ventures Ltd FAQs
The current trading price of Fischer Medical on 01-Oct-2026 16:59 is ₹33.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 30-Sep-2026 the market cap of Fischer Medical stood at ₹2,340.6 Cr
The latest P/E ratio of Fischer Medical as of 30-Sep-2026 is 0.00.
The latest P/B ratio of Fischer Medical as of 30-Sep-2026 is 5.68.
The 52-week high of Fischer Medical is ₹121.5 and the 52-week low is ₹31.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fischer Medical is ₹13.57 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Fischer Medical Ventures Ltd is a below average quality company.
The key valuation ratios of Fischer Medical Ventures Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Fischer Medical Ventures Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Fischer Medical Ventures Ltd
No data to display
You have 44 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
